CURE Pharmaceutical Names Veteran Executive as Chief Financial Officer
November 14, 2018 07:25 ET
|
CURE Pharmaceutical
OXNARD, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has tapped Alex Katz to be the company’s...
Prominent Biotech Investor Gene Salkind Adds Another $2M Investment in CURE Pharmaceutical
November 01, 2018 07:25 ET
|
CURE Pharmaceutical
OXNARD, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has announced that the company secured a $2 million investment...
CURE Pharmaceutical to Present at CannX 2018 International Medical Cannabis Conference
October 10, 2018 07:25 ET
|
CURE Pharmaceutical
OXNARD, Calif., Oct. 10, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, will be presenting at this year's CannX Conference on October...
CURE Pharmaceutical Secures Patent for Oral Thin Film Containing Bioactive Cannabinoid Molecules
September 25, 2018 08:45 ET
|
CURE Pharmaceutical
LOS ANGELES, Sept. 25, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, announced the allowance of an oral thin film patent (U.S. Patent...
Cure Pharmaceutical Plans to Acquire Cannabinoid-Based Drug Pipeline from Therapix Biosciences Ltd.
July 11, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., July 11, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced today that it has signed a term sheet...
CURE Pharmaceutical to Present on the Increased Bioavailability for Cannabinoids Due to New Delivery Technologies at O’Cannabiz Conference
June 05, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that CEO Rob Davidson will be presenting at the...
CURE Pharmaceutical to Showcase Company Growth at the 8th LD Micro Invitational
May 23, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, May 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 8th annual LD...
CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production
May 01, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., May 01, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced it received an investment of $500,000 from a...
CURE Pharmaceutical Secures Two Patents for the Extraction and Purification of Bioactive Cannabinoid Molecules
April 04, 2018 08:57 ET
|
CURE Pharmaceutical
LOS ANGELES, April 04, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the acquisition of two patents that ensure CURE...
CURE Pharmaceutical Reports Strong Progress and Sets Growth Roadmap for Remainder of Year
April 03, 2018 08:57 ET
|
CURE Pharmaceutical
OXNARD, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery company, today reported the company’s Q1 2018 accomplishments. The company strengthened...